ADVANCES IN MANAGEMENT OF IDIOPATHIC SCOLIOSIS

Management rests on two critical questions: whether the curve is likely to progress before cessation of growth, and whether further progression can be expected in the mature patient. With regard to both questions, we have learned a number of important lessons from mass screening and its follow-up. Along the way, a number of questionable technologies have been discarded.